Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5243]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Coming of age for CDK 4/6 inhibitors: Interactive session and close
Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy
Coming of age for CDK 4/6 inhibitors: Interactive session and close ( Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2016
Biomarkers of sensitivity and resistance
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biomarkers of sensitivity and resistance ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
26 Oct 2016
Editor's ESMO 2016 roundup
Prof Gordon McVie - Editor in Chief, ecancer
Editor's ESMO 2016 roundup ( Prof Gordon McVie - Editor in Chief, ecancer )
24 Oct 2016
ESMO 2016 conference highlights
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2016 conference highlights ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016
Left versus right sided GI tumour response in the CRYSTAL trial
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
Left versus right sided GI tumour response in the CRYSTAL trial ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
10 Oct 2016
Highlights of ESMO 2016
Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016
Cabozantinib over sunitinib for metastatic renal cell carcinoma
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
Cabozantinib over sunitinib for metastatic renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
10 Oct 2016
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI...
Dr Arndt Stahler - University of Munich, Munich, Germany
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1) ( Dr Arndt Stahler - University of Munich, Munich, Germany )
9 Oct 2016
Phase I results of a novel FGFR inhibitor
Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland
Phase I results of a novel FGFR inhibitor ( Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland )
9 Oct 2016
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer
Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer ( Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France )
8 Oct 2016
Combining drugs with radiotherapy
Prof John Staffurth - Cardiff University, Cardiff, UK
Combining drugs with radiotherapy ( Prof John Staffurth - Cardiff University, Cardiff, UK )
5 Oct 2016
A novel biomarker for paediatic tumours
Dr Kathleen Birley - UCL Institute of Child Health, London, UK
A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )
5 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation